{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:55:09Z","timestamp":1790661309579,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,7,7]],"date-time":"2016-07-07T00:00:00Z","timestamp":1467849600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s00403-016-1675-2","type":"journal-article","created":{"date-parts":[[2016,7,7]],"date-time":"2016-07-07T08:37:51Z","timestamp":1467880671000},"page":"527-530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["IL-33 circulating serum levels are increased in patients with non-segmental generalized vitiligo"],"prefix":"10.1007","volume":"308","author":[{"given":"Mario","family":"Vaccaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Mannucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gioacchino","family":"Calapai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Spatari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Barbuzza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serafinella P.","family":"Cannav\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Gangemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,7]]},"reference":[{"key":"1675_CR1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","volume":"65","author":"A Alikhan","year":"2011","unstructured":"Alikhan A, Felsten LM, Daly M, Petronic-Rosic V (2011) Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histo-pathology, etiology, and work-up. J Am Acad Dermatol 65:473\u2013491","journal-title":"J Am Acad Dermatol"},{"key":"1675_CR2","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4049\/jimmunol.179.4.2051","volume":"179","author":"Z Allakhverdi","year":"2007","unstructured":"Allakhverdi Z, Smith DE, Comeau MR, Delespesse G (2007) The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol 179:2051\u20132054","journal-title":"J Immunol"},{"key":"1675_CR3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coi.2014.09.004","volume":"31","author":"C Cayrol","year":"2014","unstructured":"Cayrol C, Girard JP (2014) L-33: an alarmin cytokine with crucial roles in innate immunity, inflamma-tion and allergy. Curr Opin Immunol 31:31\u201337","journal-title":"Curr Opin Immunol"},{"key":"1675_CR4","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.4049\/jimmunol.179.4.2551","volume":"179","author":"AA Chackerian","year":"2007","unstructured":"Chackerian AA, Oldham ER, Murphy EE, Schmitz J, Pflanz S, Kastelein RA (2007) IL-1 receptor ac-cessory protein and ST2 comprise the IL-33 receptor complex. J Immunol 179:2551\u20132555","journal-title":"J Immunol"},{"key":"1675_CR5","doi-asserted-by":"publisher","unstructured":"De la Fuente M, MacDonald TT, Hermoso MA (2015) The IL-33\/ST2 axis: role in health and disease. Cytokine Growth Factor Rev. doi: 10.1016\/j.cytogfr.2015.07.017 (Epub ahead of print)","DOI":"10.1016\/j.cytogfr.2015.07.017"},{"key":"1675_CR6","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/jcb.24614","volume":"114","author":"S Gangemi","year":"2013","unstructured":"Gangemi S, Franchina T, Minciullo PL, Profita M, Zangh\u00ec M, David A et al (2013) IL-33\/IL-31 axis: a new pathological mechanisms for EGFR tyrosine kinase inhibitors-associated skin toxicity. J Cell Biochem 114:2673\u20132676","journal-title":"J Cell Biochem"},{"key":"1675_CR7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00011-012-0443-9","volume":"61","author":"J Gl\u00fcck","year":"2012","unstructured":"Gl\u00fcck J, Rymarczyk B, Rogala B (2012) Serum IL-33 but not ST2 level is elevated in intermittent allergic rhinitis and is a marker of the disease severity. Inflamm Res 61:547\u2013550","journal-title":"Inflamm Res"},{"key":"1675_CR8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/00128071-200203050-00001","volume":"3","author":"CL Huang","year":"2002","unstructured":"Huang CL, Nordlund JJ, Boissy R (2002) Vitiligo: a manifestation of apoptosis? Am J Clin Dermatol 3:301\u2013308","journal-title":"Am J Clin Dermatol"},{"key":"1675_CR9","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2222.2011.03867.x","volume":"42","author":"R Kamekura","year":"2012","unstructured":"Kamekura R, Kojima T, Takano K, Go M, Sawada N, Himi T (2012) The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis. Clin Exp Allergy 42:218\u2013228","journal-title":"Clin Exp Allergy"},{"key":"1675_CR10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/15569527.2011.560913","volume":"30","author":"NH Kim","year":"2011","unstructured":"Kim NH, Torchia D, Rouhani P, Roberts B, Romanelli P (2011) Tumor necrosis factor-\u03b1 in vitiligo: direct correlation between tissue levels and clinical parameters. Cutan Ocul Toxicol 30:225\u2013227","journal-title":"Cutan Ocul Toxicol"},{"key":"1675_CR11","doi-asserted-by":"crossref","first-page":"e52298","DOI":"10.1371\/journal.pone.0052298","volume":"7","author":"NC Laddha","year":"2012","unstructured":"Laddha NC, Dwivedi M, Begum R (2012) Increased Tumor Necrosis Factor (TNF)-\u03b1 and its promnoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo. PLoS One 7:e52298","journal-title":"PLoS One"},{"key":"1675_CR12","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.4049\/jimmunol.177.5.3055","volume":"177","author":"T Lambe","year":"2006","unstructured":"Lambe T, Leung JC, Bouriez-Jones T, Silver K, Makinen K, Crockford TL et al (2006) CD4 T cell de-pendent autoimmunity against melanocyte neoantigen induces spontaneous vitiligo and depends upon Fas-Fas ligand interactions. J Immunol 177:3055\u20133062","journal-title":"J Immunol"},{"key":"1675_CR13","volume-title":"Type I IL-1 recep-tor (IL-1RI) as potential new therapeutic target for bronchial asthma","author":"JH Lee","year":"2010","unstructured":"Lee JH, Wang LC, Yu HH, Lin YT, Yang YH, Chiang BL (2010) Type I IL-1 recep-tor (IL-1RI) as potential new therapeutic target for bronchial asthma. Inflamm Mediat (Epub 2010 5)"},{"key":"1675_CR14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/ced.12464","volume":"40","author":"P Li","year":"2015","unstructured":"Li P, Ma H, Han D, Mou K (2015) Interleukin-33 affects cytokine production by keratinocytes in vitiligo. Clin Exp Dermatol 40:163\u2013170","journal-title":"Clin Exp Dermatol"},{"key":"1675_CR15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nri2692","volume":"10","author":"FY Liew","year":"2010","unstructured":"Liew FY, Pitman NI, McInnes IB (2010) Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 10:103\u2013110","journal-title":"Nat Rev Immunol"},{"key":"1675_CR16","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.coi.2010.10.006","volume":"22","author":"CM Lloyd","year":"2010","unstructured":"Lloyd CM (2010) IL-33 family members and asthma\u2013bridging innate and adaptive immune responses. Curr Opin Immunol 22:800\u2013806","journal-title":"Curr Opin Immunol"},{"key":"1675_CR17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.clindermatol.2013.11.011","volume":"32","author":"T Lotti","year":"2014","unstructured":"Lotti T, D\u2019Erme AM (2014) Vitiligo as a systemic disease. Clin Dermatol 32:430\u2013434","journal-title":"Clin Dermatol"},{"key":"1675_CR18","doi-asserted-by":"publisher","unstructured":"Mitsui A, Tada Y, Takahashi T, Shibata S, Kamata M, Miyagaki T,et al (2015) Serum IL-33 levels are increased in patients with psoriasis. Clin Exp Dermatol. doi: 10.1111\/ced.12670","DOI":"10.1111\/ced.12670"},{"key":"1675_CR19","first-page":"849","volume":"24","author":"S Moretti","year":"2009","unstructured":"Moretti S, Fabbri P, Baroni G, Berti S, Bani D, Berti E et al (2009) Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis. Histol Histopathol 24:849\u2013857","journal-title":"Histol Histopathol"},{"key":"1675_CR20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1359-6101(03)00002-9","volume":"14","author":"TA Moseley","year":"2003","unstructured":"Moseley TA, Haudenschild DR, Rose L, Reddi AH (2003) Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 14:155\u2013174","journal-title":"Cytokine Growth Factor Rev"},{"key":"1675_CR21","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/all.12004","volume":"67","author":"T Ohno","year":"2012","unstructured":"Ohno T, Morita H, Arae K, Matsumoto K, Nakae S (2012) Interleukin-33 in allergy. Allergy 67:1203\u20131214","journal-title":"Allergy"},{"key":"1675_CR22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10354-009-0699-z","volume":"159","author":"R Pichler","year":"2009","unstructured":"Pichler R, Sfetsos K, Badics B, Gutenbrunner S, Berg J, Aub\u00f6ck J (2009) Lymphocyte imbalance in vit-iligo patients indicated by elevated CD4+\/CD8+T-cell ratio. Wien Med Wochenschr 159:337\u2013341","journal-title":"Wien Med Wochenschr"},{"key":"1675_CR23","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.autrev.2011.02.004","volume":"10","author":"M Sandoval-Cruz","year":"2011","unstructured":"Sandoval-Cruz M, Garc\u00eda-Carrasco M, S\u00e1nchez-Porras R, Mendoza-Pinto C, Jim\u00e9nez-Hern\u00e1ndez M, Mungu\u00eda-Realpozo P et al (2011) Immunopathogenesis of vitiligo. Autoimmun Rev 10:762\u2013765","journal-title":"Autoimmun Rev"},{"key":"1675_CR24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2012.11197.x","volume":"168","author":"A Taieb","year":"2013","unstructured":"Taieb A, Alomar A, B\u00f6hm M et al (2013) Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol 168:5\u201319","journal-title":"Br J Dermatol"},{"key":"1675_CR25","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/ijd.12392","volume":"54","author":"M Vaccaro","year":"2015","unstructured":"Vaccaro M, Cannav\u00f2 SP, Imbesi S, Cristani M, Barbuzza O, Tigano V et al (2015) Increased serum levels of interleukin-23 circulating in patients with non-segmental generalized vitiligo. Int J Dermatol 54:672\u2013674","journal-title":"Int J Dermatol"},{"key":"1675_CR26","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.imbio.2015.02.005","volume":"220","author":"L Vocca","year":"2015","unstructured":"Vocca L, Di Sano C, Uasuf CG, Sala A, Riccobono L, Gangemi S, Albano GD, Bonanno A, Gagliardo R, Profita M (2015) IL-33\/ST2 axis controls Th2\/IL-31 and Th17 immune response in allergic airway diseases. Immunobiology 220:954\u2013963","journal-title":"Immunobiology"},{"key":"1675_CR27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2133.2000.03712.x","volume":"143","author":"RM Wijngaard van den","year":"2000","unstructured":"van den Wijngaard RM, Aten J, Scheepmaker A, Le Poole IC, Tigges AJ, Westerhof W et al (2000) Ex-pression and modulation of apoptosis regulatory molecules in human melanocytes: significance in vitiligo. Br J Dermatol 143:573\u2013581","journal-title":"Br J Dermatol"},{"key":"1675_CR28","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/bjd.14016","volume":"173","author":"KC Webb","year":"2015","unstructured":"Webb KC, Tung R, Winterfield LS, Gottlieb AB, Eby JM, Henning SW et al (2015) Tumour necrosis factor-\u03b1 inhibition can stabilize disease in progressive vitiligo. Br J Dermatol 173:641\u2013650","journal-title":"Br J Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-016-1675-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-016-1675-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-016-1675-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T13:58:44Z","timestamp":1498312724000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-016-1675-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["1675"],"URL":"https:\/\/doi.org\/10.1007\/s00403-016-1675-2","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,7]]}}}